ALYSSA LANDRY: Open Payments
NPI 1851026769 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 5 payments from 5 companies in 2025. Trend: 2023 $318 · 2024 $331 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $163 |
| Gilead Sciences, Inc. | 1 | $133 |
| Novo Nordisk Inc | 1 | $123 |
| Madrigal Pharmaceuticals | 1 | $123 |
| GENZYME CORPORATION | 1 | $120 |
Products named: DEXCOM G7 GSS (161), Epclusa, Wegovy, REZDIFFRA, FABRAZYME.
Industry payments across LA — which companies pay providers there.
